Lavinia Quintarelli
Verified @gmail.com
Scopus Publications
- Idiopathic cutaneous immunoglobulin G/immunoglobulin M vasculitis is likely a distinct entity: A European multicentric retrospective study
Marzia Caproni, Erkan Alpsoy, Angelo Valerio Marzano, Elena Biancamaria Mariotti, Elena Del Bianco, Beatice Bianchi, Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Carlo Alberto Maronese, Cumhur I. Başsorgun, Cord Sunderkötter
Jaad International, 2026
IgA vasculitis or Henoch-Schoenlein purpura; IgM-IgG vasculitis; anaphylactoid purpura; cutaneous vasculitis; leukocytoclastic vasculitis; non-IgA vasculitis; purpura - A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study
Lavinia Quintarelli, Irene Bonanni, Elena Biancamaria Mariotti, Laura Atzori, Clara De Simone, Camilla Vassallo, Giovanni Di Zenzo, Stefano Caccavale, Emanuele Cozzani, Gianpiero Girolomoni, Angelo Valerio Marzano, Andrea Conti, Pamela Vezzoli, Giovanni Damiani, Vito Di Lernia, Riccardo Balestri, Roberto Maglie, Alberto Corrà, Alessandro Magnatta, Marta Donati, Valentina Ruffo di Calabria, Alice Verdelli, Alessio Coi, Emiliano Antiga, Marzia Caproni
Clinical and Experimental Dermatology, 2026
Background The clinical, epidemiological and immunopathological profiles of atypical forms of pemphigus remain only partially known. Objectives To define the clinical, epidemiological and immunological characteristics, therapies and outcomes in patients with atypical pemphigus variants. Methods This was a 14-year multicentre retrospective observational study (VARIANT_P) on atypical variants of pemphigus across Italy. We collected demographic, immunopathological and clinical data, as well as information on comorbidities and prescribed treatments. Results We enrolled 61 patients [female/male sex ratio 1.77; 13 paraneoplastic pemphigus (PNP), 26 IgA pemphigus (PIgA), 22 pemphigus herpetiformis (PH)]. The median ages at onset and diagnosis were 70.6 (range 43.1–86.8) and 71.1 (range 46.9–86.9) for PNP; 62.2 (range 3.8–81.0) and 63.6 (range 4.0–82.4) for PIgA; and 49.4 (range 5.4–84.4) and 52.3 (range 5.9–85.9) for PH, respectively. The median diagnostic delay was 3.0 (range 0.0–45.6) months for PNP, 9.5 (range 1.0–140.0) months for PIgA and 2.0 (range 0–30.4) months for PH. The mortality rate was 55% (6/11) for PNP, 4% (1/26) for PIgA and 6% (1/17) for PH. Cutaneous involvement was present in all patients with PIgA and PH, and in 83% (10/12) of the patients with PNP. In contrast, oral mucosal involvement was observed in all patients with PNP with data (n = 12), but only in 8% (2/26) of those with PIgA and 21% (4/19) of those with PH. Histology, direct immunofluorescence, indirect immunofluorescence and enzyme-linked immunosorbent assay data demonstrated variable concordance with previously known data. Comorbidities included mainly solid malignancies for people with PNP, whereas cardiovascular and metabolic diseases were the most prevalent for those with PIgA and PH. Treatment mostly relied on systemic steroids and rituximab. Conclusions The VARIANT_P study contributes to data collection relating to atypical pemphigus variants in order to promote the development of specific therapeutical guidelines in the future. - Dermatitis herpetiformis, celiac disease and their impact on women and their families
Martin A. SHAHID, Elena B. MARIOTTI, Kosara DRENOVSKA, Snejina VASSILEVA, Cristina AIMO, Valentina RUFFO DI CALABRIA, Lavinia QUINTARELLI, Alessandro MAGNATTA, Simone LANDINI, Marta DONATI, Alice VERDELLI, Marzia CAPRONI
Italian Journal of Dermatology and Venereology, 2025
Dermatitis herpetiformis (DH) is the specific cutaneous manifestation of celiac disease (CD), both of which require lifelong management. A comprehensive literature review was conducted to gather evidence on gender-related differences aiming at reducing healthcare inequalities. While women tend to be more symptomatic, the diagnosis is often delayed, leading to a reduced quality of life and an increased risk of long-term complications. This may be partly a consequence of the fact that they are more likely to present with seronegative forms. Moreover, in women, reproductive issues, known to be associated with DH and CD, along with osteopenia/osteoporosis, and anemia are particularly prevalent. It should be also noted that beyond personal diagnosis, DH and CD also affect women indirectly, as they often take on caregiving roles for affected family members. The lifelong adherence to a gluten-free diet, the only effective treatment for DH, imposes a substantial lifestyle and financial burden. Gluten-free diet is frequently perceived as both gendered and class-based, placing a disproportionate strain on women and lower-income households. In this regard, recent recommendations to prioritize naturally gluten-free foods rather than "gluten-free" products, may offer some relief. However, the responsibility for acquiring the skills necessary for such dietary choices often falls predominantly on women. - An Overview of the Pathogenesis of Cutaneous Lupus Erythematosus
Alice Verdelli, Emanuela Barletta, Elena Biancamaria Mariotti, Simone Landini, Alessandro Magnatta, Valentina Ruffo di Calabria, Alberto Corrà, Lavinia Quintarelli, Irene Bonanni, Luca Sanna, Virginia Corti, Marzia Caproni
Journal of Clinical Medicine, 2025
Background/Objectives: Cutaneous lupus erythematosus (CLE) is a complex autoimmune skin disease driven by genetic predisposition, environmental triggers, and immune dysregulation. Environmental factors such as ultraviolet radiation, smoking, and certain drugs can initiate disease onset by inducing keratinocyte apoptosis. The subsequent release of nucleic acids and danger-associated molecular patterns activates pattern recognition receptors (PRRs) on keratinocytes and immune cells, leading to the production of type I and type III interferons (IFNs) and pro-inflammatory cytokines. The objective of this review is to summarize recent advances in understanding the immunopathogenesis of CLE, with particular attention to emerging cellular players and their therapeutic implications. Methods: A narrative review of the recent literature was performed, including experimental, translational, and clinical studies investigating the cellular and molecular mechanisms underlying CLE and novel targeted treatments derived from these findings. Results: Although plasmacytoid dendritic cells (pDCs) have traditionally been considered the major producers of IFN-I, recent data indicate that pDCs in CLE are functionally impaired and are not the primary source. Other cells, such as keratinocytes have emerged as key producers of IFN-I, contributing to a prelesional, IFN-rich microenvironment. This promotes the recruitment and activation of dendritic cells and other inflammatory myeloid subsets, which are now recognized as central players in amplifying local inflammation. Concurrently, T cells infiltrate the skin, where cytotoxic CD8+ T cells attack keratinocytes and CD4+ T cells further propagate inflammation via cytokine production. B cells and plasma cells produce autoantibodies, forming immune complexes that perpetuate inflammation. Neutrophils release neutrophil extracellular traps (NETs), exposing autoantigens and further stimulating IFN pathways. Macrophages contribute by presenting autoantigens, producing pro-inflammatory mediators, and failing to effectively clear apoptotic cells and immune complexes. Conclusions: The dynamic interplay between the innate and adaptive immune systems sustains the chronic inflammatory state characteristic of CLE. Based on the pathogenetic novelties, new therapeutic agents targeting specific molecules have been developed, which may improve the treatment of this complex disease in the future. - The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study
D. Bonciani, C. Della Bella, A. Corrà, A. Galano, G. Vaggelli, S. Tapinassi, A. Grassi, E. Mantengoli, A. Coi, L. Quintarelli, E. B. Mariotti, C. Aimo, V. Ruffo di Calabria, E. Garufi, V. Volpi, A. Verdelli, G. M. Rossolini, A. Bartoloni, M. M. D'Elios, M. Caproni
Journal of Dermatology, 2025
The association between psoriasis and streptococcal infection has been widely explored in both children and adults. However, the exact impact of Streptococcus pharyngeal infection on the course of psoriasis is not fully comprehended. This study explored the impact of Streptococcus pharyngeal infection on psoriasis and investigated the effectiveness of systemic antibiotic therapy in conjunction with standard topical treatment for psoriatic patients with concomitant streptococcal throat infection. The research involved 115 patients with mild‐to‐moderate psoriasis, clinically assessed using the Psoriasis Area and Severity Index (PASI). Patients with active streptococcal infection were administered adjunctive systemic antibiotic therapy along with standard local treatment for psoriasis, while psoriasis patients without evidence of infection received the local topical treatment only. Streptococcal infections were more common in psoriasis patients compared to healthy controls. A group of psoriasis patients with active streptococcal throat infections, treated with antibiotics in addition to standard topical psoriasis therapy, did not show any difference in PASI score reduction compared to those without evidence of active infection. While our study did not show a statistically significant reduction in PASI scores in psoriasis patients with streptococcal throat infections treated with antibiotics, it highlights the complex interaction between infection and psoriasis. Larger studies with longer follow‐up may better clarify this relationship, contributing to stronger evidence for or against the use of antibiotics in managing psoriasis triggered by streptococcal infections. - Stevens-Johnson syndrome/toxic epidermal necrolysis induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report
Chiara Frattini, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Valentina Ruffo di Calabria, Alessandro Magnatta, Simone Landini, Lavinia Quintarelli, Alice Verdelli, Marzia Caproni
Dermatology Reports, 2025
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but serious cutaneous reactions characterized by epidermal and mucocutaneous detachment, most often drug-induced. SJS and TEN are considered the opposite extremes of the same spectrum of disease, where the percentage of skin involvement is <10% in SJS and >30% in TEN; the in-between range is called an SJS/TEN overlap. We present the case of a 64-year-old patient who was treated with lamotrigine, an anti-epileptic drug, and developed SJS/TEN. After being hospitalized and recovering for three days due to the worsening of the clinical presentation, he was transferred to a burn center. Making an early diagnosis and identifying the appropriate drug is crucial for setting the correct treatment and reducing mortality. Advanced supportive care is required. - Bullous pemphigoid with secondary acquired reactive perforating collagenosis: a challenging clinical case report
Valentina Ruffo di Calabria, Elena Biancamaria Mariotti, Alberto Corrà, Alice Verdelli, Lavinia Quintarelli, Cristina Aimo, Giovanni Di Zenzo, Vincenza Maio, Daniela Massi, Marzia Caproni
Dermatology Reports, 2025
Bullous Pemphigoid (BP) is a common autoimmune blistering disorder with unknown aetiology. During the last decades, its association with various common comorbidities, including cardiovascular, metabolic, neuropsychiatric, and neoplastic disorders, has been established. However, in recent years an increasing number of BP cases have also been reported in association with rarer diseases, including Acquired Reactive Perforating Collagenosis (ARPC). Patients with coexisting BP and ARPC have been reported to share common clinical features including metabolic comorbidities e.g., Diabetes Mellitus (DM). As the evolution from ARPC cutaneous involvement to classic BP lesions has been more frequently described, it has been suggested that it may represent a new clinical variant of BP with a specific pathogenetic background. Here is reported a challenging case in which a typical onset of BP was later followed by the eruption of atypical ARPC lesions in a patient with multiple non-compensated metabolic and cardiovascular comorbidities. - Preserving esthetics and function: the double wedge solution for nipple-areola complex melanoma
Camilla SALVINI, Lavinia QUINTARELLI, Elisabetta MAGNATERRA, Roberto MAGLIE, Giulio TOSTI, Nicola PIMPINELLI
Italian Journal of Dermatology and Venereology, 2024
no - Reply to ‘New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination’
E. Magnaterra, E. B. Mariotti, A. Corrà, C. Aimo, L. Quintarelli, V. Ruffo di Calabria, A. Verdelli, M. Caproni
Journal of the European Academy of Dermatology and Venereology, 2024
We read with great interest ‘New onset of systemic lupus erythematosus following COVID-19 mRNA vaccination’ by Hansen et al.1 The authors present the case of a 26-year-old female with no family or personal history of systemic lupus erythematosus (SLE) who developed SLE 2 weeks after the second dose of the COVID-19 mRNA vaccination. Her clinical history was not characterized by photosensitivity or other subtle signs of a latent autoimmune condition. However, along with the onset of specific cutaneous manifestations, the laboratory findings, including mild leukopenia, positive ANA, ENA antibodies, ds-DNA antibodies, positive RNP/Sm antibodies and decreased C3 levels, were compatible with an autoimmune preclinical condition that may have been triggered by vaccination. In fact, it has been observed that autoantibodies become detectable many years before the diagnosis of SLE, and their appearance tends to follow a predictable course.2 In our perspective, it is crucial to differentiate between latent presentations and inductions. In fact, it is known that inductions have a more favourable course, while exacerbations often follow a more challenging and complex path.3, 4 In this regard, the laboratory findings, particularly the autoantibody profile, may serve as a biomarker to differentiate between the two conditions. Accordingly, we recently described a subacute cutaneous lupus erythematosus (SCLE) presenting after Pfizer COVID-19 vaccination but serologically negative,5 with no signs of recurrence nearly 2 years later. In a similar manner, drug-induced cases of dermatomyositis (DM) have been mostly reported to be characterized by pathognomic skin findings (85%) and negative serological markers.6 The potential mechanisms by which COVID-19 vaccines may trigger autoimmunity in genetically predisposed individuals have been reported to be molecular mimicry, autoantibody production and activation of the inflammasome by vaccine adjuvants.6 Notably, Sprent and King hypothesized that most reactions to COVID-19 vaccines are driven by the production of interferon type 1 (IFN-I).7 IFN-I, primarily produced by plasmacytoid dendritic cells, is a known a central player in the pathogenesis of SLE, SCLE and DM. In particular, COVID-19 infection8 and COVID-19 mRNA vaccination9 have been suggested to induce DM as a result of the production of IFN-I, promoted by the apoptosis and amplification of the innate immune response.7 However, inquiries into whether the mechanism activated in vaccine-induced DM may differ from the conventional one, potentially impacting the prognosis9 have been made. In conclusion, drug-induced interferonopathies may be characterized by specific pathogenetic pathways and usually have a more favourable outcome than latent forms. Negative serology may serve as a biomarker and a predictor of a better prognosis. None. None declared. Ethic statement is not applicable to this article. Data sharing is not applicable to this article as no new data were created or analysed in this study. - Exacerbation of clinical manifestations of bullous pemphigoid after treatment with dupilumab
Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, Valentina Ruffo di Calabria, Lavinia Quintarelli, Alice Verdelli, Marzia Caproni
Clinical and Experimental Dermatology, 2024
The article presents an adverse event that occurred after the induction phase of dupilumab, administered in another country to a patient affected by bullous pemphigoid. - A case of dermatomyositis induced by SARS-CoV-2 infection
Cristina AIMO, Elena B. MARIOTTI, Alberto CORRÀ, Lavinia QUINTARELLI, Valentina RUFFO DI CALABRIA, Beatrice BIANCHI, Elena DEL BIANCO, Alice VERDELLI, Maurizio BENUCCI, Marzia CAPRONI
Italian Journal of Dermatology and Venereology, 2024 - Linear deposits of IgM along the dermo-epidermal junction possibly associated with non-classical clinical features in bullous pemphigoid
Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, Valentina Ruffo di Calabria, Gabriele Cavazza, Lavinia Quintarelli, Alice Verdelli, Feliciana Mariotti, Giovanni Di Zenzo, Marzia Caproni
Journal of the European Academy of Dermatology and Venereology, 2024 - Clinical evidence of 595 nm pulse dye laser treatment for viral warts on hands and feet
Piero Campolmi, Lavinia Quintarelli, Irene Fusco, Lara Ronconi, Tiziano Zingoni
Skin Research and Technology, 2023 - Tralokinumab efficacy in a case of dupilumab-resistant severe atopic dermatitis complicated by eczema herpeticum
Maria E. Baffa, Carlo Pipitò, Francesca Montefusco, Stefano Senatore, Lavinia Quintarelli, Emiliano Antiga, Roberto Maglie
Journal of the European Academy of Dermatology and Venereology, 2023 - Blutendes und schnell wachsendes Knötchen am Unterarm einer 86-jährigen Frau
Elena Biancamaria Mariotti, Alberto Corrà, Andrea Gemignani, Vincenza Maio, Cristina Aimo, Lavinia Quintarelli, Valentia Ruffo di Calabria, Marzia Caproni
JDDG Journal of the German Society of Dermatology, 2023 - Bleeding and rapidly growing nodule on the forearm of an 86-year-old woman
Elena Biancamaria Mariotti, Alberto Corrà, Andrea Gemignani, Vincenza Maio, Cristina Aimo, Lavinia Quintarelli, Valentia Ruffo di Calabria, Marzia Caproni
JDDG Journal of the German Society of Dermatology, 2023 - Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine
Elisabetta MAGNATERRA, Manfredi MAGLIULO, Elena B. MARIOTTI, Valentina RUFFO DI CALABRIA, Lavinia QUINTARELLI, Alberto CORRÀ, Cristina AIMO, Alice VERDELLI, Marzia CAPRONI
Italian Journal of Dermatology and Venereology, 2023 - Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid
Roberto Maglie, Laura Mercurio, Martina Morelli, Stefania Madonna, Adele Salemme, Maria E. Baffa, Lavinia Quintarelli, Giovanni M. Di Zenzo, Emiliano Antiga, Cristina Albanesi
Experimental Dermatology, 2023 - Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection
Chiara Della Bella, Alberto Corrà, Elisabetta Mantengoli, Angelo Galano, Marisa Benagiano, Diletta Bonciani, Elena Biancamaria Mariotti, Sara Pratesi, Lavinia Quintarelli, Cristina Aimo, Alessia Grassi, Sofia D’Elios, Walter Volpi, Alice Verdelli, Alessandro Bartoloni, Gian Maria Rossolini, Mario Milco D’Elios, Marzia Caproni
Journal of Investigative Dermatology, 2023 - Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease
L. Quintarelli, E. Magnaterra, R. Maglie, A. Corrà, V. Ruffo di Calabria, C. Aimo, E.B. Mariotti, A. Verdelli, V. Maio, E. Antiga, M. Caproni
Travel Medicine and Infectious Disease, 2023 - Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019
Alberto Corrá, Francesca Barei, Giovanni Genovese, Martina Zussino, Cristina B. Spigariolo, Elena B. Mariotti, Lavinia Quintarelli, Alice Verdelli, Marzia Caproni, Angelo V. Marzano
Journal of Dermatology, 2023 - A Multimodal Approach to Laser Treatment of Extensive Hypertrophic Burn Scar: A Case Report
Piero Campolmi, Lavinia Quintarelli, Irene Fusco
American Journal of Case Reports, 2023 - Skin gluten-related disorders: new and old cutaneous manifestations to be considered
Alice Verdelli, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Lavinia Quintarelli, Valentina Ruffo di Calabria, Marta Elettra Donati, Veronica Bonciolini, Emiliano Antiga, Marzia Caproni
Frontiers in Medicine, 2023 - Environmental factors in autoimmune bullous diseases with focusing on seasonality: new insights
Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani
Dermatology Reports, 2023 - Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection
Valentina Ruffo di Calabria, Alice Verdelli, Lavinia Quintarelli, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Elena Del Bianco, Beatrice Bianchi, Vincenza Maio, Daniela Massi, Marzia Caproni
Frontiers in Immunology, 2023 - Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination
Alberto Corrà, Alice Verdelli, Elena Biancamaria Mariotti, Valentina Ruffo di Calabria, Lavinia Quintarelli, Cristina Aimo, Cord H. Sunderkötter, Marzia Caproni
Frontiers in Medicine, 2022 - The impact on the scientific community of the 2018 addendum to the CHCC
Marzia Caproni, Valentina Ruffo di Calabria, Elena Biancamaria Mariotti, Alice Verdelli, Cristina Aimo, Alberto Corrà, Lavinia Quintarelli, Walter Volpi, Erkan Alpsoy, Cord Sunderkötter
Frontiers in Medicine, 2022 - Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature
Elena Biancamaria Mariotti, Alberto Corrà, Elisa Lemmi, Lucrezia Laschi, Cristina Aimo, Lavinia Quintarelli, Walter Volpi, Francesca Nacci, Alice Verdelli, Valentina Ruffo di Calabria, Serena Guiducci, Marzia Caproni
Journal of Clinical Medicine, 2022 - Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study
Alice Verdelli, Marzia Caproni, Alessio Coi, Alberto Corrà, Donatella Degl’Innocenti, Marzia Vasarri, Lavinia Quintarelli, Valter Volpi, Emanuele Maria Cipollini, Emanuela Barletta
International Journal of Molecular Sciences, 2022 - An update on the management of refractory cutaneous lupus erythematosus
Alice Verdelli, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Valentina Ruffo di Calabria, Walter Volpi, Lavinia Quintarelli, Marzia Caproni
Frontiers in Medicine, 2022 - Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis
Cristina Aimo, Elena Biancamaria Mariotti, Alberto Corrà, Lavinia Quintarelli, Beatrice Bianchi, Alice Verdelli, Valentina Ruffo di Calabria, Marzia Caproni
Vaccines, 2022 - Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study
Lavinia Quintarelli, Alessio Coi, Roberto Maglie, Alberto Corrà, Elena Biancamaria Mariotti, Cristina Aimo, Valentina Ruffo di Calabria, Alice Verdelli, Beatrice Bianchi, Elena Del Bianco, Emiliano Antiga, Marzia Caproni
Frontiers in Immunology, 2022 - Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
Maria Efenesia Baffa, Alberto Corrà, Roberto Maglie, Elena Biancamaria Mariotti, Francesca Montefusco, Carlo Pipitò, Stefano Senatore, Lavinia Quintarelli, Marzia Caproni, Emiliano Antiga
Journal of Clinical Medicine, 2022 - Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?
Maurizio Benucci, Arianna Damiani, Maria Infantino, Mariangela Manfredi, Barbara Lari, Valentina Grossi, Elena Biancamaria Mariotti, Alberto Corrà, Cristina Aimo, Lavinia Quintarelli, Alice Verdelli, Francesca Li Gobbi, Emiliano Antiga, Marzia Caproni
Frontiers in Medicine, 2022 - Linear IGA bullous dermatosis potentially triggered by vaccination
Alberto Corrà, Veronica Bonciolini, Lavinia Quintarelli, Alice Verdelli, Marzia Caproni
International Journal of Immunopathology and Pharmacology, 2022 - Inverted-U serration pattern: a novel clue for the diagnosis of anti-laminin-γ1 pemphigoid
Stefano Senatore, Roberto Maglie, Francesca Montefusco, Lavina Quintarelli, Adele Salemme, Giovanni Di Zenzo, Emiliano Antiga
International Journal of Dermatology, 2021 - Unilateral generalised morphea successfully treated with rituximab and mycophenolate mofetil
Clinical and Experimental Rheumatology, 2021 - Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic
Alberto Corrà, Francesca Cammelli, Lavinia Quintarelli, Giuseppe Barbato, Ornella Le Rose, Adele Salemme, Giovanni Di Zenzo, Francesco Coratti, Alice Verdelli, Cristina Aimo, Elena Biancamaria Mariotti, Beatrice Bianchi, Fabio Cianchi, Marzia Caproni
Frontiers in Medicine, 2021 - T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis
Marzia Caproni, Manuela Capone, Maria Caterina Rossi, Veronica Santarlasci, Laura Maggi, Alessio Mazzoni, Beatrice Rossettini, Daniela Renzi, Lavinia Quintarelli, Beatrice Bianchi, Alessandra Ninci, Gabriele Lami, Antonio Calabrò, Lorenzo Cosmi, Francesco Annunziato, Francesco Liotta
Frontiers in Immunology, 2021 - The skin does not lie: A case of dermatitis herpetiformis in the setting of refractory celiac disease
Lavinia QUINTARELLI, Alberto CORRÀ, Roberto MAGLIE, Emiliano ANTIGA, Marzia CAPRONI
Italian Journal of Dermatology and Venereology, 2021 - Exacerbation of generalized plaque psoriasis after tuberculin test
Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni
Dermatology Reports, 2021 - Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?
Roberto Maglie, Farzan Solimani, Lavinia Quintarelli, Michael Hertl
Journal of Investigative Dermatology, 2020 - Bleeding from the oral cavity: a new case of hematohidrosis
Alberto Corrà, Lavinia Quintarelli, Marzia Caproni
International Journal of Dermatology, 2020 - Granulomatous Dermatitis and Systemic Disease: An Association to Consider
Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Francesca Portelli, Daniela Massi, Marzia Caproni
Biomed Research International, 2020 - Beeindruckendes Ansprechen auf Monotherapie mit Lymecyclin bei erosiver pustulöser Dermatose der Kopfhaut
Roberto Maglie, Lavinia Quintarelli, Marzia Caproni, Emiliano Antiga
JDDG Journal of the German Society of Dermatology, 2019 - Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris
R. Maglie, L. Quintarelli, I. Lastrucci, S. Senatore, F. Montefusco, N. Pimpinelli, E. Antiga
Clinical and Experimental Dermatology, 2019 - Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center
Vieri Grandi, Roberto Maglie, Emiliano Antiga, Margherita Vannucchi, Chiara Delfino, Irene Lastrucci, Susanna Gunnella, Stefania Ciolli, Lavinia Quintarelli, Daniela Massi, Marzia Caproni, Nicola Pimpinelli
Journal of the American Academy of Dermatology, 2019 - Is chemotherapy the best option for chronic lymphocytic leukemia associated Wells’ syndrome? Reply to “Case of Wells’ syndrome: A rare association with the clinical course of chronic lymphocytic leukemia”
Roberto Maglie, Lavinia Quintarelli, Marzia Caproni, Emiliano Antiga
Journal of Dermatology, 2019 - Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab
R. Maglie, E. Antiga, L. Quintarelli, A. Verdelli, M. Caproni
European Journal of Dermatology, 2019 - Specific dermatoses of pregnancy other than pemphigoid gestationis
Roberto Maglie, Lavinia Quintarelli, Alice Verdelli, Paolo Fabbri, Emiliano Antiga, Marzia Caproni
Giornale Italiano Di Dermatologia E Venereologia, 2019 - Dermatitis herpetiformis: Novel perspectives
Emiliano Antiga, Roberto Maglie, Lavinia Quintarelli, Alice Verdelli, Diletta Bonciani, Veronica Bonciolini, Marzia Caproni
Frontiers in Immunology, 2019 - At the Root: Cutaneous Langerhans Cell Histiocytosis
Roberto Maglie, Margherita Vannucchi, Lavinia Quintarelli, Marzia Caproni, Daniela Massi, Emiliano Antiga
American Journal of Medicine, 2018 - Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid
Diletta Bonciani, Lavinia Quintarelli, Elena Del Bianco, Beatrice Bianchi, Marzia Caproni
Journal of Dermatological Science, 2017 - Drug-induced cutaneous vasculitides
Giornale Italiano Di Dermatologia E Venereologia, 2015
